EP Patent

EP2241310A2 — Modified release formulations of emoxypine

Assigned to Sanovel Ilac Sanayi ve Ticaret AS · Expires 2010-10-20 · 16y expired

What this patent protects

The present invention is related to a modifed release pharmaceutical formulations comprising emoxypine or a pharmaceutically acceptable salt thereof and a rate controlling polymer, with at least one pharmaceutically acceptable excipient.

USPTO Abstract

The present invention is related to a modifed release pharmaceutical formulations comprising emoxypine or a pharmaceutically acceptable salt thereof and a rate controlling polymer, with at least one pharmaceutically acceptable excipient.

Drugs covered by this patent

minocycline-hydrochloride (MINOCYCLINE HYDROCHLORIDE)

Patent Metadata

Patent number: EP2241310A2
Jurisdiction: EP
Classification: —
Expires: 2010-10-20
Drug substance claim: No
Drug product claim: No
Assignee: Sanovel Ilac Sanayi ve Ticaret AS
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.